Well, I don't know that over riding a patent would necessarily mean that compensation would not be paid to GSK and Biota. Can't it mean merely that a government directs the manufacture of the drug in an emergency, ignoring manufacturing rights that are exclusive to GSK and Biota.
Anyone know what has happened in precedents?
Add to My Watchlist
What is My Watchlist?